Dolby Laboratories Inc (DLB)
NYSE
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 334.92M | 375.89M | 298.37M | 290.56M | 315.57M | 364.52M | 288.82M | 304.81M |
Operating Income | 94.09M | 109.22M | 15.94M | -3.49M | 66.22M | 108.97M | 36.78M | 60.55M |
Pre Tax Income | 99.98M | 117.28M | 23.76M | 9.03M | 80.83M | 121.75M | 50.16M | 59.73M |
Net Income | 79.38M | 95.7M | 16.4M | 9.19M | 66.98M | 97.83M | 38.44M | 58.57M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | 95.19M | 110.47M | 16.56M | -247k | 71.65M | 113.15M | 40.73M | 48.78M |
EBITDA | 113.24M | 130.46M | 36.98M | 17.64M | 84.09M | 126.99M | 55.09M | 81.91M |
Year End September 26 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 1.08B | 1.17B | 1.24B | 1.16B | 1.28B | 1.25B | 1.3B | 1.27B |
Operating Income | 248.63M | 300M | 257.08M | 218.74M | 330.52M | 206.61M | 215.75M | 272.53M |
Pre Tax Income | 256.64M | 312.87M | 282.31M | 239.72M | 354.51M | 215.28M | 250.05M | 312.48M |
Net Income | 201.8M | 122.25M | 255.15M | 231.36M | 310.23M | 184.09M | 200.66M | 261.83M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0.988 | 0.592 | 1.274 | 1.153 | 1.535 | 0.942 | 1.049 | 1.373 |
EBIT | 247.27M | 294.92M | 257.08M | 227.18M | 351.5M | 209.11M | 221.97M | 274.3M |
EBITDA | 332.94M | 381.28M | 342.2M | 309.62M | 426.38M | 295.07M | 298.31M | 348.09M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.